Multiple myeloma in the older adult: better prospects, more challenges.
about
Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectivesTowards Stratified Medicine in Plasma Cell MyelomaChemotherapy and Stem Cell Transplantation Increase p16INK4a Expression, a Biomarker of T-cell Aging.Risk of vertebral compression fractures in multiple myeloma patients: A finite-element study.Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).Recent progress in relapsed multiple myeloma therapy: implications for treatment decisions.Management of Elderly Patients with Plasma Cell Myeloma.Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations.Future distribution of multiple myeloma in the United States by sex, age, and race/ethnicity.Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma.Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy.Incidence and survival of hematological cancers among adults ages ≥75 years.Once-Weekly 1.6 mg/m2 Bortezomib BCD Regimen in Elderly Patients with Newly Diagnosed Multiple Myeloma Who are Unfit for Standard Dose Chemotherapy.A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
P2860
Q26799104-E5E6B1A7-E806-4679-9D22-C91C8CC0912BQ28074994-0506AD34-6836-454B-89BD-924AFFC330A0Q37309695-ABA35185-B637-4ED4-8AFE-676C4758F3A0Q37606354-04F70A10-6C43-4779-BE28-21D1DA90BC37Q38385471-C9CEE861-8489-49CE-BBB3-34E2E33FE48CQ38389362-B776551F-A66B-4DE5-92E2-EE14EDD0B404Q38554884-8BB955AE-6788-4A46-AD90-5A92B82C4B2CQ38714809-CECE56B6-65D5-45A9-865E-D68C21BB2D2AQ38757067-AE248F86-AA6E-4200-B355-A87B3487BE58Q39001325-E9666011-4F46-4BA9-A931-EBA64BF05A35Q41602673-0845EEED-DC1D-417D-B995-079DDE602C0BQ43096798-F4923849-4A9D-49E3-854B-FCA0A35D6DF2Q47587127-1C2BBB84-A06C-4E18-85AD-C3D5CD28D3CFQ48196873-D51AABBB-4920-4ECA-936E-C704C17B7B45Q51795374-85AE1B23-D1B8-4A6D-81E6-72A818E6D326Q52911976-D27C62F3-32C6-4104-9EA9-636CB237F638Q54342150-B5FA64EA-DAFD-422C-A8EC-4ED0CEE1886FQ54970050-6E5AFFE4-2B64-4162-86E2-B79DE8A1D9DBQ55431025-75DE05E3-87F3-4FCB-893B-6389ADAF29FF
P2860
Multiple myeloma in the older adult: better prospects, more challenges.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multiple myeloma in the older adult: better prospects, more challenges.
@ast
Multiple myeloma in the older adult: better prospects, more challenges.
@en
Multiple myeloma in the older adult: better prospects, more challenges.
@nl
type
label
Multiple myeloma in the older adult: better prospects, more challenges.
@ast
Multiple myeloma in the older adult: better prospects, more challenges.
@en
Multiple myeloma in the older adult: better prospects, more challenges.
@nl
prefLabel
Multiple myeloma in the older adult: better prospects, more challenges.
@ast
Multiple myeloma in the older adult: better prospects, more challenges.
@en
Multiple myeloma in the older adult: better prospects, more challenges.
@nl
P2093
P2860
P356
P1476
Multiple myeloma in the older adult: better prospects, more challenges.
@en
P2093
Ashley Rosko
Sascha A Tuchman
Tanya M Wildes
P2860
P304
P356
10.1200/JCO.2014.55.1028
P407
P577
2014-08-01T00:00:00Z